With the US now withdrawn from the WHO, how badly will that affect the seasonal flu vaccine development?

Avery Davis Avery Davis Oct 07, 2020 · 2 mins read
Share this

The World Health Organization (WHO) is the global organization responsible for coordinating efforts to prevent and control infectious diseases. One of the critical functions of the WHO is to work with governments, experts, and stakeholders to develop and distribute influenza vaccines every year. However, with the United States’ recent decision to withdraw from the WHO, many have wondered how badly it will impact the seasonal flu vaccine’s development.

The seasonal flu, commonly known as the flu, is a viral infection that causes respiratory illnesses. Influenza viruses circulate every year, particularly during the fall and winter months, and can result in mild to severe symptoms that range from fever, cough, sore throat, and body aches to severe complications such as pneumonia or hospitalization. To combat this common illness, the WHO works closely with scientists and policymakers worldwide to develop seasonal influenza vaccines.

The seasonal flu vaccine is unique in that it is produced annually and tailored to the strains of the influenza virus that are expected to be most widespread in the upcoming flu season. Every year, the WHO works with influenza experts from around the world to identify these strains and produces guidance on the composition of the vaccine each year.

However, with the US now withdrawn from the WHO, concerns have been raised about how badly this will affect the development of the seasonal flu vaccine. The United States’ contribution to the WHO has been significant, providing roughly one-quarter of the WHO’s budget for public health emergencies, including pandemic preparedness and response.

Without US involvement, the WHO’s influenza vaccine development efforts may very well be affected. The United States plays a significant role in providing funding, expertise, and technology to combat infectious diseases. The lack of American input may mean less funding for vaccine research and less involvement from American scientists and researchers who have been an integral part of the WHO’s flu vaccine programs.

Furthermore, the lack of US involvement could impact global coordination efforts, which are vital for developing and distributing influenza vaccines on a global scale. The US has significant resources to aid in vaccine distribution, including logistical support and supplies, which won’t be available to the same extent without the country’s involvement.

Overall, the US withdrawal from the WHO is a significant setback for global health initiatives, including vaccine development efforts. However, it remains to be seen how badly it will affect the seasonal flu vaccine. While the WHO will undoubtedly face challenges, other countries will need to step up to fill the void, ensuring that the vaccine continues to be developed and distributed to those who need it most. The world needs global cooperation now more than ever, and while the US’s absence is a blow, it’s important to remember that the flu doesn’t discriminate, and we’re all in this together.

Avery Davis
Written by Avery Davis
Unleashing potential with passion and purpose.